Related content

Epstein–Barr virus‐associated mononucleosis caused by weekly low‐dose methotrexate therapy in a rheumatoid arthritis patient

By Shoda H.   Nakazaki K.   Izutsu K.   Tanaka R.   Komagata Y.   Misaki Y.   Yamamoto K.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 2, 2006-04 ,pp. : 152-153

Informa Healthcare

Access to resources Recommend Favorite

Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients

By Kameda Hideto   Amano Koichi   Sekiguchi Naoya   Takei Hirofumi   Ogawa Hiroe   Nagasawa Hayato   Takeuchi Tsutomu  

Modern Rheumatology, Vol. 14, Iss. 6, 2004-12 ,pp. : 442-446

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and efficacy of low-dose methotrexate in patients with rheumatoid arthritis

By Hiraga Yoshiko   Yuhki Yoshimitsu   Itoh Katsumi   Tadano Kohji   Takahashi Yasushi   Mukai Masaya  

Modern Rheumatology, Vol. 14, Iss. 2, 2004-06 ,pp. : 135-142

Springer Publishing Company

Access to resources Recommend Favorite

Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate: Risk factors and response to folic acid

By Suzuki Y   Uehara R   Tajima C   Noguchi A   Ide M   Ichikawa Y   Mizushima Y  

Scandinavian Journal of Rheumatology, Vol. 28, Iss. 5, 1999-09 ,pp. : 273-281

Informa Healthcare

Access to resources Recommend Favorite

Rheumatoid nodulosis during methotrexate therapy in a patient with rheumatoid arthritis

By Matsushita Isao   Uzuki Miwa   Matsuno Hiroaki   Sugiyama Eiji   Kimura Tomoastu  

Modern Rheumatology, Vol. 16, Iss. 6, 2006-12 ,pp. : 401-403

Springer Publishing Company

Access to resources Recommend Favorite